Viewing Study NCT03987867


Ignite Creation Date: 2025-12-25 @ 12:37 AM
Ignite Modification Date: 2026-01-01 @ 8:39 PM
Study NCT ID: NCT03987867
Status: UNKNOWN
Last Update Posted: 2020-07-07
First Post: 2019-06-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Autologous CIK Cell Immunotherapy Combination With PD-1 Inhibitor and Chemotherapy in the Advanced NSCLC
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module